GSK, a British drugmaker, recently beat Q4 earnings estimates. The company is our FDI of the Month January 2025.
GlaxoSmithKline "deliberately" discontinued a widely-used asthma medication in order to reap profits and families suffered, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback